Epigenetic Reader Domain
Browse by type, application, or key specifications such as purity, grade, packaging, and handling requirements.
750 products
Popular Products
- PFI 4, bromodomain and PHD finger containing 1Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥97%● In Stock — US Item #: P287481View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N-(1,3-dimethyl-2-oxo-6-pyrrolidin-1-ylbenzimidazol-5-yl)-2-methoxybenzamide
- SMILES
- CN1C2=C(C=C(C(=C2)NC(=O)C3=CC=CC=C3OC)N4CCCC4)N(C1=O)C
- InChIKey
- QCIJLRJBZDBVDB-UHFFFAOYSA-N
- InChI
- 1S/C21H24N4O3/c1-23-17-12-15(22-20(26)14-8-4-5-9-19(14)28-3)16(25-10-6-7-11-25)13-18(17)24(2)21(23)27/h4-5,8-9,12-13H,6-7,10-11H2,1-3H3,(H,22,26)
- Synonyms
- N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxybenzamide
- GSK6853CAS: 1910124-24-1 Formula: C22H27N5O3 Molecular Weight: 409.48● In Stock — US Item #: G275395View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxobenzimidazol-5-yl]-2-methoxybenzamide
- SMILES
- CC1CNCCN1C2=CC3=C(C=C2NC(=O)C4=CC=CC=C4OC)N(C(=O)N3C)C
- InChIKey
- FQWDVNSBYDXPIO-CQSZACIVSA-N
- InChI
- show more
- Synonyms
- N-[2,3-Dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxybenzamide | (R)-N-(1...
- SGC-CBP30, Inhibitor of CREB binding protein;Inhibitor of E1A binding protein p300CAS: 1613695-14-9 EC Number: 106-820-6 PubChem CID: 72201027 Formula: C28H33ClN4O3 Molecular Weight: 509.04Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%● In Stock — US Item #: S357869View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 4-[(2S)-1-[2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)benzimidazol-1-yl]propan-2-yl]morpholine
- SMILES
- CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)CC(C)N5CCOCC5
- InChIKey
- GEPYBHCJBORHCE-SFHVURJKSA-N
- InChI
- show more
- OF 1, bromodomain and PHD finger containing 1;bromodomain and PHD finger containing 3Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%(HPLC)● In Stock — US Item #: O286836View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 4-bromo-N-(6-methoxy-1,3-dimethyl-2-oxobenzimidazol-5-yl)-2-methylbenzenesulfonamide
- SMILES
- CC1=C(C=CC(=C1)Br)S(=O)(=O)NC2=CC3=C(C=C2OC)N(C(=O)N3C)C
- InChIKey
- YUNQZQREIHWDQT-UHFFFAOYSA-N
- InChI
- 1S/C17H18BrN3O4S/c1-10-7-11(18)5-6-16(10)26(23,24)19-12-8-13-14(9-15(12)25-4)21(3)17(22)20(13)2/h5-9,19H,1-4H3
- Synonyms
- OF-1, >=98% (HPLC) | 9,10-Anthraguinone | AKOS000481248 | EX-A2269 | A16000 | NCGC00384195-05 | GTPL9523 | 4-bromo-N-...
- OTX015, Bromodomain and extra-terminal motif (BET) inhibitorCAS: 202590-98-5 Formula: C25H22ClN5O2S Molecular Weight: 491.99Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%● In Stock — US Item #: O125058View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- show more
- SMILES
- CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C
- InChIKey
- GNMUEVRJHCWKTO-FQEVSTJZSA-N
- InChI
- show more
- Synonyms
- OTX 015 | OTX-015 | 2-((6S)-4-(4-CHLOROPHENYL)-2,3,9-TRIMETHYL-6H-THIENO(3,2- F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-6...
- CPI203, Inhibitor of bromodomain containing 4CAS: 1446144-04-2 Formula: C19H18ClN5OS Molecular Weight: 399.9Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%(HPLC)● In Stock — US Item #: C167316View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetamide
- SMILES
- CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)N)C4=CC=C(C=C4)Cl)C
- InChIKey
- QECMENZMDBOLDR-AWEZNQCLSA-N
- InChI
- 1S/C19H18ClN5OS/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)22-14(8-15(21)26)18-24-23-11(3)25(18)19/h4-7,14H,8H2,1-3H3,(H2,21,26)/t14-/m0/s1
- Synonyms
- (6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide
- BI 2536, Serine/threonine-protein kinase PLK1 inhibitorMoligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%● In Stock — US Item #: B129994View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
- SMILES
- CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C
- InChIKey
- XQVVPGYIWAGRNI-JOCHJYFZSA-N
- InChI
- show more
- Synonyms
- (R)-4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl...
- OXF BD 02CAS: 1429129-68-9 Formula: C18H17NO3 Molecular Weight: 295.33● In Stock — US Item #: O287867View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-[hydroxy(phenyl)methyl]phenol
- SMILES
- CC1=C(C(=NO1)C)C2=CC(=CC(=C2)O)C(C3=CC=CC=C3)O
- InChIKey
- FEQUIPXIENTMJN-UHFFFAOYSA-N
- InChI
- 1S/C18H17NO3/c1-11-17(12(2)22-19-11)14-8-15(10-16(20)9-14)18(21)13-6-4-3-5-7-13/h3-10,18,20-21H,1-2H3
- Synonyms
- 3-(3,5-Dimethyl-4-isoxazolyl)-5-hydroxy-α-phenylbenzenemethanol
- PF CBP1● In Stock — US Item #: P288278View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 4-[2-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[2-(4-propoxyphenyl)ethyl]benzimidazol-1-yl]ethyl]morpholine
- SMILES
- CCCOC1=CC=C(C=C1)CCC2=NC3=C(N2CCN4CCOCC4)C=CC(=C3)C5=C(ON=C5C)C
- InChIKey
- CGWBJJZOKGZCSJ-UHFFFAOYSA-N
- InChI
- show more
- Synonyms
- 5-(Dimethyl-1,2-oxazol-4-yl)-1-[2-(morpholin-4-yl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-1,3-benzodiazole
- I-BET 151 dihydrochloride● In Stock — US Item #: I287715View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 7-(3,5-dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-pyridin-2-ylethyl]-3H-imidazo[4,5-c]quinolin-2-one;dihydrochloride
- SMILES
- CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)C(C)C5=CC=CC=N5)OC.Cl.Cl
- InChIKey
- UFLKDZBLUNJNJS-FFXKMJQXSA-N
- InChI
- show more
- Synonyms
- I-BET151 dihydrochloride | GSK1210151A dihydrochloride | 7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydroxy-8-methoxy-1-[(1R...
- I-BET151, Inhibitor of bromodomain containing 2;Inhibitor of bromodomain containing 3;Inhibitor of bromodomain containing 4Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%● In Stock — US Item #: I124882View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 7-(3,5-dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-pyridin-2-ylethyl]-3H-imidazo[4,5-c]quinolin-2-one
- SMILES
- CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)C(C)C5=CC=CC=N5)OC
- InChIKey
- VUVUVNZRUGEAHB-CYBMUJFWSA-N
- InChI
- 1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1
- Synonyms
- BDBM50380682 | GTPL7518 | 1GH | DTXSID10680599 | 2H-Imidazo[4,5-c]quinolin-2-one, 7-(3,5-dimethyl-4-isoxazolyl)-1,3-d...
- I-BRD9, Inhibitor of bromodomain containing 9CAS: 1714146-59-4 Formula: C22H22F3N3O3S2 Molecular Weight: 497.55Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%(HPLC)● In Stock — US Item #: I287753View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N'-(1,1-dioxothian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide
- SMILES
- CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F
- InChIKey
- WRUWGLUCNBMGPS-UHFFFAOYSA-N
- InChI
- show more
- Synonyms
- 5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyri...
Fast Shipping Same-day shipping on in-stock items
Technical Details Quality & specification info on every product page
Pack Size Options Multiple packaging sizes with pricing access from listing
R&D Use Only Products supplied for research and development use
Frequently Asked Questions
Which compounds are listed for Epigenetic Reader Domain?
Compounds associated with Epigenetic Reader Domain are grouped here under the Epigenetics classification, with mechanism, structure, and reported potency shown per entry. Use it as a starting shortlist rather than a final selection.
How does Epigenetic Reader Domain sit within Epigenetics?
Epigenetic Reader Domain is one target listing within the Epigenetics classification. Compounds here may also appear under related targets, so check the selectivity data rather than assuming the annotation is exclusive.
What data should I check before ordering a compound from Epigenetic Reader Domain?
For compounds listed under Epigenetic Reader Domain, check purity — typically 98% or better by HPLC — the reported potency and the assay it was measured in, solubility and recommended stock solvent, and storage and stability. Batch-specific values are given on the Certificate of Analysis. All products are supplied for professional research and development use only, and are not for use in humans, animals, diagnostics, or therapy.
How do I find related targets or backup compounds for Epigenetic Reader Domain?
Browse the parent Epigenetics listing to reach targets neighbouring Epigenetic Reader Domain, and use the structure search to find analogs of a compound that worked. Unlisted compounds and bulk quantities: [email protected]. We supply verified businesses, research institutions, universities, and government agencies.